Literature DB >> 2030719

Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

K R Tuttle1, J L Bruton, M C Perusek, J L Lancaster, D T Kopp, R A DeFronzo.   

Abstract

BACKGROUND: Many patients with insulin-dependent diabetes mellitus have an increase in the glomerular filtration rate and renal enlargement early in the course of their disease. Both these changes may be risk factors for the later development of diabetic nephropathy. Their cause is not known, but they could be due to augmented renal responses to the increase in plasma amino acid concentrations that occurs when dietary protein intake is high, a factor known to increase glomerular filtration and renal blood flow in normal subjects.
METHODS: We measured the glomerular filtration rate and renal plasma flow after an overnight fast and during an infusion of amino acids in 12 patients with insulin-dependent diabetes mellitus and 9 normal subjects. The diabetic patients were studied when they were hyperglycemic, when they were euglycemic after an insulin infusion for 36 hours, and after intensive insulin therapy for 3 weeks. Kidney volume was measured by ultrasonography before and after the period of intensive insulin therapy.
RESULTS: The glomerular filtration rate and renal plasma flow were normal after fasting when the patients were hyperglycemic (mean [+/- SE] fasting plasma glucose level, 11.5 +/- 0.7 mmol per liter). After the amino acid infusion, these values increased more in the patients (glomerular filtration rate, 2.65 +/- 0.07 ml per second per 1.73 m2 of body-surface area; renal plasma flow, 13.30 +/- 0.68 ml per second per 1.73 m2; P less than 0.05 for both) than in the normal subjects (2.25 +/- 0.08 and 11.20 +/- 0.65 ml per second per 1.73 m2, respectively). The 36-hour infusion of insulin in the diabetic patients did not alter the glomerular filtration rate or renal plasma flow either before or during the amino acid infusion. After three weeks of intensive insulin therapy (fasting plasma glucose level, 5.3 +/- 0.2 mmol per liter), the glomerular filtration rate and renal plasma flow after the amino acid infusion (2.33 +/- 0.03 and 11.30 +/- 0.43 ml per second per 1.73 m2, respectively) were similar to those in the normal subjects. The kidney volumes in the normal subjects and the patients with diabetes were 219 +/- 14 and 312 +/- 14 ml per 1.73 m2, respectively (P less than 0.01); the volume decreased to 267 +/- 22 ml per 1.73 m2 (P less than 0.001) in the diabetic patients after three weeks of intensive insulin therapy, which was not significantly different from the volume in the normal subjects (P = 0.1).
CONCLUSIONS: Conventionally treated diabetic patients who have normal renal function while fasting have augmented renal hemodynamic responses to increased plasma amino acid concentrations. The concomitant decrease in these hemodynamic responses and in kidney size with strict glycemic control suggests that these phenomena are related and influenced by the metabolic state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030719     DOI: 10.1056/NEJM199106063242304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

Review 1.  Pathogenesis of diabetic nephropathy.

Authors:  Claudia van Dijk; Tomas Berl
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 3.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 4.  Dapagliflozin for the treatment of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Expert Opin Pharmacother       Date:  2013-06-26       Impact factor: 3.889

5.  Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.

Authors:  T Pelikánová; I Smrcková; J Krízová; J Stríbrná; V Lánská
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 6.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

Review 7.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

8.  Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study.

Authors:  M Janner; S E Knill; P Diem; K A Zuppinger; P E Mullis
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

9.  Soybeans ameliolate diabetic nephropathy in rats.

Authors:  Young Eun Choi; Soo Kyung Ahn; Won Taek Lee; Jong Eun Lee; Seung Hwa Park; Bang Bu Yoon; Kyung Ah Park
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

10.  Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients.

Authors:  Bernhard Glodny; Verena Unterholzner; Bernadette Taferner; Karin J Hofmann; Peter Rehder; Alexander Strasak; Johannes Petersen
Journal:  BMC Urol       Date:  2009-12-23       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.